6 Areas to Watch in a D&O Review By Evan Bundschuh While much language has remained fairly constant, here are six areas of new or renewed interest for buyers and their brokers.
Can Insurers Do More to Reduce Injuries? By Peter Blackmore A simple risk-profiling tool lets insurers better assist employers in managing their workers' compensation costs and impacts.
Is a Reciprocal Insurer Right for You? By Andre Breedt Many do not appreciate how the structure of an insurer can be an important consideration in a purchasing decision.
Potential Key to Tackling Opioid Issues By Nancy Grover Urine drug testing can help identify injured workers who may be abusing, misusing or diverting prescribed opioids.
Marijuana and Workers' Comp Studies of NFL players, plus last Tuesday's votes in nine states, suggest marijuana will be a big issue in workers' comp soon. Here's how to prepare.
The Need to Educate on General Liability Painful misunderstandings arise over what general liability policies actually cover and what risks they simply won’t mitigate.
A Tipping Point for Commercial Lines Culture (the idea that “We’ve always done it this way”) and not technology stands in the way of an automated process -- and a breakthrough.
Value of Onsite Physical Therapy By Nancy Grover Many injured workers are receiving "therapy on demand," which makes PT easily accessible at a cost comparable to that in clinics.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.